Creative Planning’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,168
Closed -$12.1K 3596
2024
Q3
$12.1K Buy
+1,168
New +$19.4K ﹤0.01% 3165
2021
Q2
Sell
-720
Closed -$281K 2129
2021
Q1
$281K Buy
+720
New +$355K ﹤0.01% 1833
2020
Q1
Sell
-2,385
Closed -$2.71M 1888
2019
Q4
$2.71M Buy
+2,385
New +$2.59M 0.01% 423
2019
Q2
Sell
-386
Closed -$787K 2030
2019
Q1
$787K Sell
386
-17
-4% -$29.9K ﹤0.01% 827
2018
Q4
$517K Buy
403
+198
+97% +$304K ﹤0.01% 952
2018
Q3
$388K Buy
205
+18
+10% +$37.2K ﹤0.01% 1236
2018
Q2
$381K Buy
+187
New +$426K ﹤0.01% 1225
2018
Q1
Sell
-140
Closed -$323K 2050
2017
Q4
$323K Buy
+140
New +$284K ﹤0.01% 1319
2017
Q3
Sell
-55
Closed -$75K 2099
2017
Q2
$75K Sell
55
-3,646
-99% -$4.4M ﹤0.01% 2192
2017
Q1
$4.36M Buy
3,701
+2
+0.1% +$2.04K 0.02% 232
2016
Q4
$2.96M Buy
3,699
+1,784
+93% +$1.42M 0.02% 304
2016
Q3
$1.68M Sell
1,915
-77
-4% -$55.8K 0.01% 430
2016
Q2
$1.12M Sell
1,992
-46
-2% -$26.1K 0.01% 489
2016
Q1
$1.12M Buy
2,038
+342
+20% +$210K 0.01% 463
2015
Q4
$1.41M Buy
1,696
+1,194
+238% +$1.19M 0.01% 399
2015
Q3
$556K Buy
+502
New +$915K ﹤0.01% 696
2015
Q2
Sell
-14
Closed -$22K 1318
2015
Q1
$22K Buy
14
+9
+180% +$11.9K ﹤0.01% 2635
2014
Q4
$6K Buy
+5
New +$3.34K ﹤0.01% 3383

Other funds holding BLUE

Creative Planning's BLUE Position: Q4 2024 in Review

Creative Planning sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,168 shares — an estimated $12.1K sold.

Creative Planning first reported a position in BLUE in Q4 2014 and held it in 18 quarters. The position peaked at $4.36M in Q1 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Creative Planning reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Creative Planning sold 1,168 bluebird bio shares in Q4 2024, an estimated $12.1K.
  • Creative Planning first reported a position in bluebird bio in Q4 2014 and held it in 18 quarters.
  • Creative Planning's bluebird bio position peaked at $4.36M in Q1 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.